Drugs / MNC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01187654 | May 2009 → Sep 2012 | myocardial infarction | Royan Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01187654 ↗ |
| Modality | Cell therapy | “bone marrow derived MNC” NCT01187654 ↗ |
| Route | Other | “intra coronary injection” NCT01187654 ↗ |